Zhejiang Conba Pharmaceutical
Zhejiang Conba Pharmaceutical Co., Ltd. (founded in 1969, listed in 2004, stock code 600572) is a holding subsidiary and main member enterprise of Conba Group Co. Ltd and is a listed pharmaceutical enterprise integrating R&D, herbs plantation & extraction, drug production and sales. Conba is a flagship enterprise in the domestic herbal medicine industry and a top-ten enterprise in the national Chinese medicine industry.
The company, with headquarters in Hangzhou, owns medicine production lines all over the country conforming to GMP requirements, has set up numerous planting bases according with GACP and has established a first-rate domestic modern herbal medicine industrial park conforming to GMP in Lanxi. It has been certificated by GMP, CEP, GEP (CCCMHPIE), Kosher, Halal, ISO9001 and ISO14001.
The company has established the first special extraction production line for Ginkgo leaf extract in China conforming to CGMP with an annual yield of 300 tons to produce series high-standard Ginkgo leaves extracts, and has become the largest supply base for APIs of Ginkgo leaf preparation in China. The Company focuses on herb separation and extraction as well as modern herbal medicine development and application. It has set up a number of special extraction production lines in accordance with European and American GMP international standards, and developed new herbal products by methods of modern extraction and separation technologies.